Y-Intercept (HK)’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Buy
+5,466
New +$373K 0.01% 1358
2026
Q1
Sell
-45,549
Closed -$3.07M 1755
2025
Q4
$3.07M Buy
45,549
+28,648
+170% +$1.93M 0.07% 417
2025
Q3
$1.24M Sell
16,901
-77,700
-82% -$5.16M 0.03% 872
2025
Q2
$4.92M Buy
+94,601
New +$5.38M 0.12% 224
2024
Q2
Sell
-24,900
Closed -$1.01M 1590
2024
Q1
$1.01M Buy
24,900
+3,127
+14% +$117K 0.08% 384
2023
Q4
$805K Sell
21,773
-13,401
-38% -$505K 0.07% 401
2023
Q3
$1.34M Buy
+35,174
New +$1.44M 0.13% 229
2023
Q2
Sell
-13,501
Closed -$516K 1452
2023
Q1
$516K Buy
+13,501
New +$633K 0.06% 517

Other funds holding HALO

Y-Intercept (HK)'s HALO Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Halozyme (HALO) in Q2 2026: 5,466 shares worth $428K. The stake represents 0.01% of the portfolio and ranks #1358 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in HALO as recently as Q4 2025.

Y-Intercept (HK) first reported a position in HALO in Q1 2023 and has held it in 8 quarters since. The position peaked at $4.92M in Q2 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Y-Intercept (HK) held 5,466 shares of Halozyme worth $428K as of Q2 2026.
  • Halozyme was a new Y-Intercept (HK) position in Q2 2026.
  • Halozyme made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1358 holding.
  • Y-Intercept (HK) first reported a position in Halozyme in Q1 2023 and has held it in 8 quarters since.
  • Y-Intercept (HK)'s Halozyme position peaked at $4.92M in Q2 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.